Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · IEX Real-Time Price · USD
0.780
-0.008 (-1.08%)
At close: May 2, 2024, 3:54 PM
0.810
+0.030 (3.85%)
After-hours: May 2, 2024, 5:17 PM EDT
Achilles Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Hold
Price Target
$2.83
Upside
+262.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $8 → $2 | Buy → Hold | Downgrades | $8 → $2 | +156.41% | Apr 5, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $6 | Strong Buy | Maintains | $11 → $6 | +669.23% | Apr 5, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $7 → $0.5 | Strong Buy → Sell | Downgrades | $7 → $0.5 | -35.90% | Dec 14, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,310.26% | Aug 7, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +1,310.26% | May 11, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +2,079.49% | Dec 7, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +925.64% | Dec 7, 2022 |
| JP Morgan | JP Morgan | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Apr 26, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 26, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 26, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 26, 2021 |